GLP-1 medications were marketed as a game changer in diabetes care and weight loss. They certainly have changed the conversations with employers as they experience a sharp increase in utilization, with the cost having a significant impact on budget. Manufacturer research has shown significant improvement in A1c control, weight loss and perhaps even cardiovascular risk. It has been touted as the wonder drug. Yet, everyone has heard of the side effects, dependence on the drug long term, off label use, and the financial impact. Listen to our panel of experts discuss how they have been able to successfully leverage these medications for the right target patient and what restrictions are put in place to reduce side effects, poor outcomes, and inappropriate use.
Obesity Medicine Provider